查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1525316

全球功能服务提供者市场规模研究，按类型、阶段、应用和区域预测 2022-2032

Global Functional Service Providers Market Size Study, by Type, by Stage, by Application and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球功能服务供应商（FSP）市场估值约为144.3亿美元，预计2024年至2032年将以8.49%的年复合成长率（CAGR）成长。提供关键支援公司透过为各种临床开发和批准后活动提供熟练的劳动力。这些职能的外包使公司能够专注于其核心竞争力，降低营运成本并提高药物开发流程的效率。市场成长是由研发投资的增加和临床试验数量的增加所推动的。此外，人工智慧、机器学习和巨量资料分析等先进技术的采用正在增强金融服务提供者的能力。这些技术简化了流程，提高了资料准确性，并实现了更有效率的试验管理。

FSP 越来越多的采用主要是因为它们能够在不影响品质或控制的情况下将固定成本转变为变动成本。美国生物製药产业30多年来一直处于全球领先地位，在研发方面投入巨资，满足了对功能服务提供者的需求。此外，临床试验的增加和对专业服务的需求正在推动市场成长。此外，临床试验日益复杂和成本进一步推动了对 FSP 的需求，FSP 提供临床监测、资料管理、统计程式设计和医学写作等解决方案。然而，临床试验的高成本和复杂性以及整合新技术的问题限制了 2024-2032 年预测期内全球功能服务提供者市场的成长。

全球功能服务供应商市场的主要区域包括北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。到 2023 年，北美由于其先进的医疗基础设施、对製药和生物技术研究的大量投资以及对专业临床服务的高需求，在收入方面占据市场主导地位。该地区由主要製药公司和临床研究组织组成的完善网路推动了 FSP 解决方案的采用。此外，北美严格的监管标准和对创新临床实践的重视也有助于其市场领先地位。临床试验日益复杂以及对营运效率的关注进一步增强了该地区的突出地位，使其成为全球 FSP 市场的关键参与者。此外，在患者人数众多、试验成本较低以及有利的监管政策等因素的推动下，亚太地区预计将出现最高的成长率。

目录

第 1 章：全球功能服务供应商市场执行摘要

  • 全球功能服务供应商市场规模及预测（2022-2032）
  • 区域概要
  • 分部摘要
    • 按类型
    • 按阶段
    • 按申请
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 2 章：全球功能服务提供者市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包含与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的角度）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第 3 章：全球功能服务供应商市场动态

  • 市场驱动因素
    • 增加研发投入
    • 临床试验数量不断增加
  • 市场挑战
    • 临床试验成本高且复杂
    • 整合新技术的问题
  • 市场机会
    • FSP 在新兴市场的扩张
    • 融合人工智慧、机器学习等先进技术

第 4 章：全球功能服务供应商市场产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的五力影响分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：全球功能服务供应商市场规模与预测：按类型 - 2022-2032

  • 细分仪表板
  • 全球功能服务供应商市场：类型收入趋势分析，2022 年和 2032 年
    • 临床监测
    • 医学写作
    • 资料管理
    • 药物警戒
    • 生物统计学
    • 程式设计
    • 学习规划
    • 其他的

第 6 章：全球功能服务供应商市场规模与预测：按阶段 - 2022-2032 年

  • 细分仪表板
  • 全球功能服务供应商市场：2022 年和 2032 年阶段收入趋势分析
    • 临床开发
    • 批准后

第 7 章：全球功能服务供应商市场规模与预测：按应用分类 - 2022-2032

  • 细分仪表板
  • 全球功能服务供应商市场：2022 年和 2032 年应用收入趋势分析
    • 生物製药公司
    • 生技公司
    • 医疗器材公司

第 8 章：全球功能服务供应商市场规模与预测：按地区 - 2022-2032

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • Icon Plc (Ireland)
    • PPD Inc. (US)
    • Quanticate International Limited (UK)
    • BioPoint Inc. (US)
    • RHO, Inc. (US)
    • Wuxi AppTec Co., Ltd. (China)
    • KPS Life, LLC (US)
    • IQVIA Inc. (US)
    • Laboratory Corporation of America Holdings (US)
    • Parexel International Corporation (US)

第 10 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
简介目录

The global functional service providers (FSP) market was valued at approximately USD 14.43 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.49% from 2024 to 2032. Functional service providers offer critical support to biopharmaceutical and biotechnology companies by providing a skilled workforce for various clinical development and post-approval activities. The outsourcing of these functions allows companies to focus on their core competencies, reduce operational costs, and improve efficiency in drug development processes. The market growth is driven by the increasing R&D investments and the rising number of clinical trials. Furthermore, the adoption of advanced technologies, such as artificial intelligence, machine learning, and big data analytics, is enhancing the capabilities of FSPs. These technologies streamline processes, improve data accuracy, and enable more efficient trial management.

The increasing adoption of FSPs is largely due to their ability to turn fixed costs into variable costs without compromising on quality or control. The US biopharmaceutical industry, which has been a global leader for over 30 years, invests significantly in R&D, contributing to the demand for functional service providers. Additionally, the rise in clinical trials and the need for specialized services are driving the market growth. Furthermore, the growing complexity and cost of clinical trials further fuel the demand for FSPs, which provide solutions such as clinical monitoring, data management, statistical programming, and medical writing. However, high cost and complex nature of clinical trials and issues with integrating new technologies restrain growth for the Global Functional Service Providers Market during the forecast period 2024-2032.

The key region in the Global Functional Service Providers Market includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America dominates the market in terms of revenue due to its advanced healthcare infrastructure, significant investment in pharmaceutical and biotechnology research, and high demand for specialized clinical services. The region's well-established network of major pharmaceutical companies and clinical research organizations drives the adoption of FSP solutions. Additionally, North America's stringent regulatory standards and emphasis on innovative clinical practices contribute to its market leadership. The growing complexity of clinical trials and a focus on operational efficiency further enhance the region's prominence, making it a key player in the global FSP market. Furthermore, Asia-Pacific is expected to witness the highest growth rate, driven by factors such as a high patient population, lower costs of conducting trials, and favourable regulatory policies.

Major market players included in this report are:

  • IQVIA Inc. (US)
  • Parexel International Corporation (US)
  • Laboratory Corporation of America Holdings (US)
  • Icon Plc (Ireland)
  • PPD Inc. (US)
  • Quanticate International Limited (UK)
  • BioPoint Inc. (US)
  • RHO, Inc. (US)
  • Wuxi AppTec Co., Ltd. (China)
  • KPS Life, LLC (US)

The detailed segments and sub-segment of the market are explained below:

By Type

  • Clinical Monitoring
  • Medical Writing
  • Data Management
  • Pharmacovigilance
  • Biostatistics
  • Programming
  • Study Design
  • Others

By Stage

  • Clinical Development
  • Post Approval

By Application

  • Biopharma Companies
  • Biotech Companies
  • Medical Devices Companies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Functional Service Providers Market Executive Summary

  • 1.1. Global Functional Service Providers Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Stage
    • 1.3.3. By Application
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Functional Service Providers Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Functional Service Providers Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing R&D investments
    • 3.1.2. Rising number of clinical trials
  • 3.2. Market Challenges
    • 3.2.1. High cost and complex nature of clinical trials
    • 3.2.2. Issues with integrating new technologies
  • 3.3. Market Opportunities
    • 3.3.1. Expansion of FSPs in emerging markets
    • 3.3.2. Integration of advanced technologies such as AI and machine learning

Chapter 4. Global Functional Service Providers Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Functional Service Providers Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Functional Service Providers Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Clinical Monitoring
    • 5.2.2. Medical Writing
    • 5.2.3. Data Management
    • 5.2.4. Pharmacovigilance
    • 5.2.5. Biostatistics
    • 5.2.6. Programming
    • 5.2.7. Study Design
    • 5.2.8. Others

Chapter 6. Global Functional Service Providers Market Size & Forecasts by Stage 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Functional Service Providers Market: Stage Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Clinical Development
    • 6.2.2. Post Approval

Chapter 7. Global Functional Service Providers Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Functional Service Providers Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Biopharma Companies
    • 7.2.2. Biotech Companies
    • 7.2.3. Medical Devices Companies

Chapter 8. Global Functional Service Providers Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Functional Service Providers Market
    • 8.1.1. U.S. Functional Service Providers Market
      • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Stage breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Functional Service Providers Market
  • 8.2. Europe Functional Service Providers Market
    • 8.2.1. U.K. Functional Service Providers Market
    • 8.2.2. Germany Functional Service Providers Market
    • 8.2.3. France Functional Service Providers Market
    • 8.2.4. Spain Functional Service Providers Market
    • 8.2.5. Italy Functional Service Providers Market
    • 8.2.6. Rest of Europe Functional Service Providers Market
  • 8.3. Asia-Pacific Functional Service Providers Market
    • 8.3.1. China Functional Service Providers Market
    • 8.3.2. India Functional Service Providers Market
    • 8.3.3. Japan Functional Service Providers Market
    • 8.3.4. Australia Functional Service Providers Market
    • 8.3.5. South Korea Functional Service Providers Market
    • 8.3.6. Rest of Asia Pacific Functional Service Providers Market
  • 8.4. Latin America Functional Service Providers Market
    • 8.4.1. Brazil Functional Service Providers Market
    • 8.4.2. Mexico Functional Service Providers Market
    • 8.4.3. Rest of Latin America Functional Service Providers Market
  • 8.5. Middle East & Africa Functional Service Providers Market
    • 8.5.1. Saudi Arabia Functional Service Providers Market
    • 8.5.2. South Africa Functional Service Providers Market
    • 8.5.3. Rest of Middle East & Africa Functional Service Providers Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Icon Plc (Ireland)
    • 9.3.2. PPD Inc. (US)
    • 9.3.3. Quanticate International Limited (UK)
    • 9.3.4. BioPoint Inc. (US)
    • 9.3.5. RHO, Inc. (US)
    • 9.3.6. Wuxi AppTec Co., Ltd. (China)
    • 9.3.7. KPS Life, LLC (US)
    • 9.3.8. IQVIA Inc. (US)
    • 9.3.9. Laboratory Corporation of America Holdings (US)
    • 9.3.10. Parexel International Corporation (US)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes